BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10862066)

  • 1. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP.
    Ba-Ssalamah A; Heinz-Peer G; Schima W; Schibany N; Schick S; Prokesch RW; Kaider A; Teleky B; Wrba F; Lechner G
    J Magn Reson Imaging; 2000 Jun; 11(6):665-72. PubMed ID: 10862066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.
    Vogl TJ; Schwarz W; Blume S; Pietsch M; Shamsi K; Franz M; Lobeck H; Balzer T; del Tredici K; Neuhaus P; Felix R; Hammerstingl RM
    Eur Radiol; 2003 Feb; 13(2):262-72. PubMed ID: 12598989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography.
    Senéterre E; Taourel P; Bouvier Y; Pradel J; Van Beers B; Daures JP; Pringot J; Mathieu D; Bruel JM
    Radiology; 1996 Sep; 200(3):785-92. PubMed ID: 8756932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography.
    Lencioni R; Donati F; Cioni D; Paolicchi A; Cicorelli A; Bartolozzi C
    MAGMA; 1998 Dec; 7(2):76-87. PubMed ID: 9951768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the diagnostic efficacy of SPIO enhanced MRI in patients with focal hepatic lesions--comparison with CECT and CTAP].
    Kasugai H; Katayama N; Sakai S; Yamakawa T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2311-5. PubMed ID: 12484062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging.
    Strotzer M; Gmeinwieser J; Schmidt J; Fellner C; Seitz J; Albrich H; Zirngibl H; Feuerbach S
    Acta Radiol; 1997 Nov; 38(6):986-92. PubMed ID: 9394654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography.
    Tanimoto A; Wakabayashi G; Shinmoto H; Nakatsuka S; Okuda S; Kuribayashi S
    J Gastroenterol; 2005 Apr; 40(4):371-80. PubMed ID: 15870974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT].
    Jung G; Poll L; Cohnen M; Saleh A; Vogler H; Wettstein M; Willers R; Mödder U; Koch JA
    Rofo; 2005 Nov; 177(11):1571-7. PubMed ID: 16302139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidetector helical CT plus superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions in cirrhotic liver: a comparison with multi-phase CT during hepatic arteriography.
    Yukisawa S; Okugawa H; Masuya Y; Okabe S; Fukuda H; Yoshikawa M; Ebara M; Saisho H
    Eur J Radiol; 2007 Feb; 61(2):279-89. PubMed ID: 17070663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.
    Oudkerk M; van den Heuvel AG; Wielopolski PA; Schmitz PI; Borel Rinkes IH; Wiggers T
    Radiology; 1997 May; 203(2):449-56. PubMed ID: 9114103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT.
    Kondo H; Kanematsu M; Hoshi H; Murakami T; Kim T; Hori M; Matsuo M; Nakamura H
    AJR Am J Roentgenol; 2000 Apr; 174(4):947-54. PubMed ID: 10749228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
    Kim YK; Kwak HS; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography.
    Kwak HS; Lee JM; Kim CS
    Eur Radiol; 2004 Mar; 14(3):447-57. PubMed ID: 14531005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging.
    Halavaara JT; Lamminen AE; Bondestam S; Standertskjöld-Nordenstam CG; Hamberg LM
    J Comput Assist Tomogr; 1994; 18(6):897-904. PubMed ID: 7962796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
    Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
    AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
    Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
    Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.
    Namkung S; Zech CJ; Helmberger T; Reiser MF; Schoenberg SO
    J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT.
    Bluemke DA; Paulson EK; Choti MA; DeSena S; Clavien PA
    AJR Am J Roentgenol; 2000 Dec; 175(6):1653-8. PubMed ID: 11090399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.